Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and Evaluation of Repurposed Etoricoxib Loaded Nanoemulsion for Improving Anticancer Activities against Lung Cancer Cells
Shadab Md, Nabil A. Alhakamy, Waleed S. Alharbi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13284-13284
Open Access | Times Cited: 19

Showing 19 citing articles:

Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs
Preeti, Sharda Sambhakar, Rohit Malik, et al.
Scientifica (2023) Vol. 2023, pp. 1-25
Open Access | Times Cited: 94
COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers
Paul Rodrigues, Harun Bangali, Ahmad Hammoud, et al.
Medical Oncology (2024) Vol. 41, Iss. 1
Closed Access | Times Cited: 16
Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing
Afaf El‐Malah, Magdy M. Gineinah, Pran Kishore Deb, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 827-827
Open Access | Times Cited: 51
Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice
Tuancheng Feng, Huan Du, Cha Yang, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 9
Boosting the Anticancer Activity of Sunitinib Malate in Breast Cancer through Lipid Polymer Hybrid Nanoparticles Approach
Mohammed Muqtader Ahmed, Md. Khalid Anwer, Farhat Fatima, et al.
Polymers (2022) Vol. 14, Iss. 12, pp. 2459-2459
Open Access | Times Cited: 32
Preparation and Evaluation of Chitosan Coated PLGA Nanoparticles Encapsulating Ivosidenib with Enhanced Cytotoxicity Against Human Liver Cancer Cells
Bader B. Alsulays, Alhussain Aodah, Mohammad Ahmed, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3461-3473
Open Access | Times Cited: 7
Simultaneous pulmonary administration of celecoxib and naringin using a nebulization-friendly nanoemulsion: A device-targeted delivery for treatment of lung cancer
Ramy Said-Elbahr, Maha Nasr, Mohamed A. Alhnan, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 5, pp. 611-622
Closed Access | Times Cited: 26
Nanoemulsion Therapy: A Paradigm Shift in Lung Cancer Management
Rakesh Pahwa, Gulshan Sharma, Jatin Chhabra, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106227-106227
Closed Access | Times Cited: 5
Enhanced cytotoxicity of osimertinib nanocrystals against lung cancer: Preparation, characterization and cytotoxicity studies against A549 cell lines
Md. Khalid Anwer, Mohd. Aamir Mirza, Mohammad Aleemuddin, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106805-106805
Closed Access
Lung cancer: Current and new drug delivery systems
Anoushka Mukharya, Rahul Pokale, Ritu Kudarha, et al.
Elsevier eBooks (2025), pp. 177-199
Closed Access
Preparation and Evaluation of Diosmin-Loaded Diphenylcarbonate-Cross-Linked Cyclodextrin Nanosponges for Breast Cancer Therapy
Md. Khalid Anwer, Mohammed Muqtader Ahmed, Mohammed F. Aldawsari, et al.
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 19-19
Open Access | Times Cited: 17
Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles
Joanna Kuźmińska, Agnieszka Sobczak, Aleksandra Majchrzak‐Celińska, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2104-2104
Open Access | Times Cited: 10
Nanocrystallization Improves the Solubilization and Cytotoxic Effect of a Poly (ADP-Ribose)-Polymerase-I Inhibitor
Amer S. Alali, Mohd Abul Kalam, Mohammed Muqtader Ahmed, et al.
Polymers (2022) Vol. 14, Iss. 22, pp. 4827-4827
Open Access | Times Cited: 11
Quantification of Etoricoxib in Low Plasma Volume by UPLC-PDA and Application to Preclinical Pharmacokinetic Study
Sapir Ifrah, Daniel Porat, Mordechai Deutsch, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 507-507
Open Access | Times Cited: 2
Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy
Ravinder Verma, Lakshita Rao, Diksha Nagpal, et al.
Recent Patents on Nanotechnology (2023) Vol. 18, Iss. 4, pp. 395-414
Closed Access | Times Cited: 6
Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells
Ibrahim A. Aljuffali, Md. Khalid Anwer, Mohammed Muqtader Ahmed, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1549-1549
Open Access | Times Cited: 4
Selective COX-2 Inhibitor Etoricoxib’s Liposomal Formulation Attenuates M2 Polarization of TAMs and Enhances its Anti-metastatic Potential
Usmani Mohammed Akif, Javed Miyan, Rafquat Rana, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 2, pp. 551-566
Closed Access | Times Cited: 3
Kombinasi Teknik Pembentukan Kokristal dan Ball milling untuk Peningkatan Disolusi Etoricoxib
Sharon Susanto, Saleh Wikarsa, Yuda Prasetya Nugraha
Jurnal Ilmiah Medicamento (2024) Vol. 10, Iss. 1, pp. 22-34
Open Access
Association of COX-inhibitors with cancer patients’ survival under chemotherapy and radiotherapy regimens: a real-world data retrospective cohort analysis
Lucas E. Flausino, Isabella Nevoni Ferreira, Wen‐Jan Tuan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1

Scroll to top